Curis Lifesciences IPO allotment status will be finalized soon after receiving an overwhelming response from investors. The ₹28 crore IPO, which opened on November 7, 2025, and closed on November 11, 2025, saw exceptional demand — closing with a massive oversubscription of 69.25 times.
Curis Lifesciences IPO Subscription Status
The Curis Lifesciences IPO witnessed tremendous participation from all investor categories:
- Qualified Institutional Buyers (QIBs): Subscribed around 52x
- Non-Institutional Investors (NIIs): Subscribed over 25x
- Retail Individual Investors (RIIs): Subscribed nearly 20x
This extraordinary subscription shows investors’ strong confidence in Curis Lifesciences’ business model and future growth prospects.
How to Check Curis Lifesciences IPO Allotment Status
Investors who applied for this IPO can check their Curis Lifesciences IPO allotment status through either the registrar’s website (MUFG Intime India Pvt. Ltd.) or the NSE platform once the allotment is released.
1. Check Allotment on MUFG Intime India Pvt. Ltd. Website
Follow these steps to check your Curis Lifesciences IPO allotment status:
- Visit the official allotment page:
👉 https://in.mpms.mufg.com/Initial_Offer/public-issues.html - Select “Curis Lifesciences Limited” from the dropdown menu.
- Choose one of the following options: Application Number, DP/Client ID, or PAN.
- Enter your details correctly and complete the captcha verification.
- Click “Submit” to view your allotment details.
2. Check Allotment on the NSE Platform
You can also verify your Curis Lifesciences IPO allotment on the NSE website:
- Visit https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
- Choose Equity & SME IPO bid details
- From the dropdown menu, select the symbol
- Enter your PAN and Application Number
- Click Submit to view your IPO allotment status.
Curis Lifesciences IPO Anchor Allocation
Before the IPO opened to the public, Curis Lifesciences raised ₹7.79 crore through its anchor book on November 6, 2025, by allotting 6,09,000 equity shares at ₹128 each to six institutional investors, including:
- Sanshi Fund-I
- Maiq Growth Scheme – Long Only
- Strategic Sixth Sense Capital Fund
- Viney Growth Fund
- Zeta Global Funds (OEIC) PCC Ltd – Zeta Series A Fund PC
- Moneywise Financial Services Pvt. Ltd.
This strong anchor participation reflects market confidence in the company’s fundamentals and growth potential.
About Curis Lifesciences Limited
Curis Lifesciences Limited is a research-driven pharmaceutical company focusing on innovation in drug formulation and healthcare solutions. The company’s strong product pipeline and scalable operations have made it a preferred choice among institutional investors.
Disclaimer
At Finowings, we take utmost care and diligence in presenting market-related content. However, unintentional errors or omissions may occasionally occur. The information provided above is for informational purposes only and should not be construed as investment advice.
Post a Comment